[G17-10] Nivolumab Squamous cell carcinoma of the head and neck - Addendum to A17-24

Last updated 17.11.2017

Project no.:
G17-10

Commission:
Commission awarded on 09.10.2017 by the Federal Joint Committee (G-BA).

Report type:
Addendum

Status:
Commission completed

Department/Division:
Drug Assessment

Application field:
Cancer

Note:

If, in the course of the discussions on a commission of the G-BA, a need for further revision arises, IQWiG presents its report in the form of an addendum. The G-BA decides on the number of patients in the SHI target population.

Federal Joint Committee (G-BA)

2017-11-17 A G-BA decision was published.

G-BA documents on this decision

Contact

Info Service

Subscribe to daily updated information on projects, calls for tender, and events as well as our press releases.

Contact form

Questions about commissions, publications and press releases can be sent to us via this form.